We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$393B
AUM Growth
+$46.5B
Cap. Flow
+$16.2B
Cap. Flow %
4.12%
Top 10 Hldgs %
14.79%
Holding
5,596
New
456
Increased
2,467
Reduced
1,888
Closed
410

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.23B
2
AMZN icon
Amazon
AMZN
+$792M
3
V icon
Visa
V
+$508M
4
T icon
AT&T
T
+$423M
5
JNJ icon
Johnson & Johnson
JNJ
+$422M

Sector Composition

Rank Sector Weight
1 Technology 13.44%
2 Financials 10.8%
3 Healthcare 10.08%
4 Consumer Discretionary 7.71%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIL
4976
DELISTED
Hill International, Inc. Common Stock
HIL
$96K ﹤0.01%
30,410
-2,132
-7% -$6.38K
BRMK.WS
4977
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$95K ﹤0.01%
+250,000
New +$76.2K
ASNA
4978
DELISTED
Ascena Retail Group, Inc.
ASNA
$95K ﹤0.01%
12,339
-23,048
-65% -$189K
FENC icon
4979
Fennec Pharmaceuticals
FENC
$332M
$92K ﹤0.01%
+14,224
New +$76.4K
GALT icon
4980
Galectin Therapeutics
GALT
$196M
$92K ﹤0.01%
32,076
-9,516
-23% -$33.1K
ORGO icon
4981
Organogenesis Holdings
ORGO
$305M
$92K ﹤0.01%
+19,131
New +$121K
STXS icon
4982
Stereotaxis
STXS
$126M
$92K ﹤0.01%
+17,325
New +$68.8K
ALNA
4983
DELISTED
Allena Pharmaceuticals
ALNA
$92K ﹤0.01%
33,784
-49,232
-59% -$162K
NYMX
4984
DELISTED
Nymox Pharmaceutical Corp
NYMX
$91K ﹤0.01%
41,278
+8,900
+27% +$17.6K
VERU icon
4985
Veru
VERU
$36M
$90K ﹤0.01%
+2,682
New +$59.9K
SSI
4986
DELISTED
Stage Stores Inc
SSI
$90K ﹤0.01%
+11,070
New +$42.9K
CVIA
4987
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$89K ﹤0.01%
43,689
-106,425
-71% -$172K
LCTX icon
4988
Lineage Cell Therapeutics
LCTX
$269M
$88K ﹤0.01%
98,833
+53,721
+119% +$44.8K
RMTI icon
4989
Rockwell Medical
RMTI
$28.4M
$88K ﹤0.01%
328
+11
+3% +$2.77K
JE
4990
DELISTED
Just Energy Group Inc
JE
$88K ﹤0.01%
1,596
+824
+107% +$59.2K
PXLW icon
4991
Pixelworks
PXLW
$38.2M
$87K ﹤0.01%
1,840
+393
+27% +$16.1K
GRAF.WS
4992
DELISTED
Graf Industrial Corp. Warrants (each exercisable for three-quarters of one share of common stock, ea
GRAF.WS
$87K ﹤0.01%
198,000
ACRS icon
4993
Aclaris Therapeutics
ACRS
$726M
$86K ﹤0.01%
45,709
+3,767
+9% +$6.24K
SUPV
4994
Grupo Supervielle
SUPV
$828M
$86K ﹤0.01%
23,410
+1,614
+7% +$4.83K
VSTM icon
4995
PUT
Verastem
VSTM
$510M
$86K ﹤0.01%
+5,367
New +$77.2K
NWHM
4996
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$86K ﹤0.01%
18,449
-10,275
-36% -$46.8K
TFFP
4997
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$85K ﹤0.01%
+635
New +$81.5K
FMCIW
4998
DELISTED
Forum Merger II Corporation Warrant
FMCIW
$83K ﹤0.01%
180,000
LHC.WS
4999
DELISTED
Leo Holdings Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exe
LHC.WS
$83K ﹤0.01%
125,000
SYBX
5000
DELISTED
Synlogic
SYBX
$82K ﹤0.01%
2,124
+637
+43% +$21.4K

Similar funds

Goldman Sachs's Q4 2019 Portfolio in Review

As of Q4 2019, Goldman Sachs held 5,596 positions worth $393B, up 13% from $346B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs deployed $16.2B of net new capital in Q4 2019, opening 456 new positions and adding to 2,467 existing holdings. Its largest new stake was Sprout Social: 10,378,809 shares worth $167M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.19B trimmed.

  • Goldman Sachs's largest Q4 2019 buy was Sprout Social: 10,378,809 shares worth $167M.
  • Goldman Sachs added most to Microsoft in Q4 2019, an estimated $1.23B increase.
  • Goldman Sachs's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.19B.
  • Goldman Sachs fully exited Celgene Corp in Q4 2019, selling an estimated $740M.
  • Goldman Sachs's ten largest holdings make up 15% of its $393B portfolio in Q4 2019.
  • Goldman Sachs opened 456 new positions and closed 410 in Q4 2019.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $393B.

Based on Goldman Sachs's 13F filing for Q4 2019, filed 14 Feb 2020.